TOP PICK
Medimmune
Has a flu virus vaccine and they expect sales will pick up. They have other respiratory products which continue to do well.
biotechnology / pharmaceutical
TOP PICK
Medimmune
Their flu vaccine looks promising. A lot of cash flow. Trading at 20 X next years earnings.
biotechnology / pharmaceutical
Showing 1 to 2 of 2 entries
  • «
  • 1
  • »

Medimmune(MEDI-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Medimmune is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Medimmune(MEDI-Q) Frequently Asked Questions

What is Medimmune stock symbol?

Medimmune is a OTC stock, trading under the symbol MEDI-Q on the (). It is usually referred to as or MEDI-Q

Is Medimmune a buy or a sell?

In the last year, there was no coverage of Medimmune published on Stockchase.

Is Medimmune a good investment or a top pick?

Medimmune was recommended as a Top Pick by on . Read the latest stock experts ratings for Medimmune.

Why is Medimmune stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Medimmune worth watching?

In the last year 0 stock analysts on Stockchase covered Medimmune. The stock is worth watching.

What is Medimmune stock price?

On , Medimmune (MEDI-Q) stock closed at a price of $.